Literature DB >> 10446390

Palmitoylation of GAP-43 by the ER-Golgi intermediate compartment and Golgi apparatus.

R E McLaughlin1, J B Denny.   

Abstract

Palmitoylation of the neuronal plasticity protein GAP-43 has previously been shown to occur at the plasma membrane, but the site of initial palmitoylation has not been identified. To identify this organelle we have incubated GAP-43 with various subcellular fractions and have analyzed palmitoylation by the Triton X-114 partitioning method. In vitro-translated [(35)S]methionine-labeled GAP-43 was incubated with plasma membrane, nuclei, mitochondria, Golgi apparatus and a rough microsome preparation that contained the ER-Golgi intermediate compartment (ERGIC), but not plasma membrane or Golgi apparatus. GAP-43 partitioned into Triton X-114 in the presence of plasma membrane, Golgi, and ERGIC membranes, but not nuclei or mitochondria. Partitioning caused by the ERGIC was blocked by pretreatment of the membranes with the palmitoylation inhibitors dithiothreitol, tunicamycin, and low temperature, and by treatment of GAP-43 with iodoacetamide. The time course of partitioning agreed closely with the time course of incorporation of radioactive palmitate into proteins as reported previously. Because the ERGIC has a broad distribution in the cell, our results provide evidence that the ERGIC is the initial site of GAP-43 palmitoylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446390     DOI: 10.1016/s0167-4889(99)00074-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae.

Authors:  J B McCabe; L G Berthiaume
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  Membrane trafficking of heterotrimeric G proteins via the endoplasmic reticulum and Golgi.

Authors:  David Michaelson; Ian Ahearn; Martin Bergo; Stephen Young; Mark Philips
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

3.  Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43.

Authors:  John B Denny
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

4.  Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity.

Authors:  Edward B Thorp; Joseph A Boscarino; Hillary L Logan; Jeffrey T Goletz; Thomas M Gallagher
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1.

Authors:  Hao-Ping Liu; Chih-Ching Wu; Yu-Sun Chang
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

6.  Subcellular localization of herpes simplex virus type 1 UL51 protein and role of palmitoylation in Golgi apparatus targeting.

Authors:  Naoki Nozawa; Tohru Daikoku; Tetsuo Koshizuka; Yohei Yamauchi; Tetsushi Yoshikawa; Yukihiro Nishiyama
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Importance of conserved cysteine residues in the coronavirus envelope protein.

Authors:  Lisa A Lopez; Ambere J Riffle; Steven L Pike; Douglas Gardner; Brenda G Hogue
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

8.  Palmitoylation is not required for trafficking of human anion exchanger 1 to the cell surface.

Authors:  Joanne C Cheung; Reinhart A F Reithmeier
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

9.  A crosslinking analysis of GAP-43 interactions with other proteins in differentiated N1E-115 cells.

Authors:  Callise M Ollom; John B Denny
Journal:  Int J Mol Sci       Date:  2008-09-16       Impact factor: 6.208

10.  TRIM31 promotes Atg5/Atg7-independent autophagy in intestinal cells.

Authors:  Eun A Ra; Taeyun A Lee; Seung Won Kim; Areum Park; Hyun Jin Choi; Insook Jang; Sujin Kang; Jae Hee Cheon; Jin Won Cho; Ji Eun Lee; Sungwook Lee; Boyoun Park
Journal:  Nat Commun       Date:  2016-05-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.